Association between Systemic Lupus Erythematosus and Refractory Ulcerative Colitis: What are our Therapeutic Options?

Yassine Chait; Nacir Oussama; Ait Errami Adil; Samlani Zouhour; Krati Khadija; Oubaha Sofia

Authors

Yassine Chait
Nacir Oussama
Ait Errami Adil
Samlani Zouhour
Krati Khadija
Oubaha Sofia

Keywords:

Abstract

Abstract not found

Downloads

How to Cite

Association between Systemic Lupus Erythematosus and Refractory Ulcerative Colitis: What are our Therapeutic Options?. (2023). Global Journal of Medical Research, 23(K3), 15-23. https://medicalresearchjournal.org/index.php/GJMR/article/view/102349

Download Citation

References

H Stevens, L Ostlere, M Rustin (1994) Systemic lupus erythematosus in association with ulcerative colitis: related autoimmune diseases. 130(3), 385-389.

Osamu Ishikawa, Yoshiki Miyachi, Kinichi Fujita, Seiichi Takenoshita, Yukio Nagamachi, Junko Hirato (1995) Ulcerative Colitis Associated with Preceding Systemic Lupus Erythematosus. 22(4), 289-291.

H Mansour, S Arafa, W Shehata (2018) Systemic lupus erythematosus with inflammatory bowel disease-ulcerative colitis: case report. 27(7), 1198-1201.

J Font, X Bosch, J Ferrer, F Pérez-Villa, M Ingelmo (1988) SYSTEMIC LUPUS ERYTHEMATOSUS AND ULCERATIVE COLITIS. 331(8588), 770.

I Koutroubakis, H Kritikos, I Mouzas, S Spanoudakis, A Kapsoritakis, E Petinaki (1998) Association between ulcerative colitis and systemic lupus erythematosus: report of two cases. 10(5), 437-439.

R Amelia, S Supriono (2014) 17 Year Old Female Patient with Systemic Lupus Erythematosus and Ulcerative Colitis. 15(1), 6-63.

I Koutroubakis, A Pena (1997) Genetics of inflammatory bowel disease. 3, 13-26.

J Batchelor (1993) SYSTEMIC LUPUS ERYTHEMATOSUS AND GENES WITHIN THE HLA REGION. 32(1), 13-15.

David Rubin, Ashwin Ananthakrishnan, Corey Siegel, Bryan Sauer, Millie Long (2019) ACG Clinical Guideline: Ulcerative Colitis in Adults. 114(3), 384-413.

D Medeiros, D Isenberg (2009) Systemic lupus erythematosus and ulcerative colitis. 18(8), 762-763.

D Hallegua, D Wallace (2000) Gastrointestinal manifestations of systemic lupus erythematosus. 12(5), 379-385.

D Wallace (1993) Gastrointestinal manifestations and related liver and biliary disorders. 42, 410-417.

Bruce Hoffman, Warren Katz (1980) The gastrointestinal manifestations of systemic lupus erythematosus: A review of the literature. 9(4), 237-247.

X-P Tian, X Zhang (2010) Gastrointestinal involvement in systemic lupus erythematosus: Insight into pathogenesis, diagnosis and treatment. 16(24), 2971.

O Nitzan, M Elias, W Saliba (2006) Systemic lupus erythematosus and inflammatory bowel disease. 17(5), 313-318.

Camilla Vedove, Micol Del Giglio, Donatella Schena, Giampiero Girolomoni (2009) Drug-induced lupus erythematosus. 301(1), 99-105.

Augusto Vaglio, Peter Grayson, Paride Fenaroli, Davide Gianfreda, Valeria Boccaletti, Gian Ghiggeri, Gabriella Moroni (2018) Drug-induced lupus: Traditional and new concepts. 17(9), 912-918.

I Griffiths, S Kane (1977) Sulphasalazine-induced lupus syndrome in ulcerative colitis. 2, 1188.

Sreedhar Subramanian, Vijay Yajnik, Bruce Sands, Garret Cullen, Joshua Korzenik (2011) Characterization of patients with infliximab-induced lupus erythematosus and outcomes after retreatment with a second anti-TNF agent. 17(1), 99-104.

Hiroyuki Yamashita, Yo Ueda, Hoshimi Kawaguchi, Akitake Suzuki, Yuko Takahashi, Hiroshi Kaneko, Toshikazu Kano, Akio Mimori (2012) Systemic lupus erythematosus complicated by Crohn's disease: a case report and literature review. 12(1), 174.

M Principi, A Di Leo, M Ingrosso, A Pisani, S Marangi, A Amoruso, C Panella, A Francavilla, Enzo Ierardi (2004) Lupus Nephritis Improvement After Anti‐tumor Necrosis Factor Alpha Monoclonal Antibody (Infliximab) Treatment for Crohn's Disease: A Case Report. 26(2), 243-248.

Paul Rutgeerts, William Sandborn, Brian Feagan, Walter Reinisch, Allan Olson, Jewel Johanns, Suzanne Travers, Daniel Rachmilewitz, Stephen Hanauer, Gary Lichtenstein, Willem De Villiers, Daniel Present, Bruce Sands, Jean Colombel (2005) Infliximab for Induction and Maintenance Therapy for Ulcerative Colitis. 353(23), 2462-2476.

E Garcia-Planella, E Domènech, M Esteve-Comas, I Bernal, E Cabré, J Boix (2003) Development of antinuclear antibodies and its clinical impact in patients with Crohn's disease treated with chimeric monoclonal anti-TNFα antibodies (infliximab). 15(4), 351-354.

R Mageed, D Isenberg (2002) Tumour necrosis factor alpha in systemic lupus erythematosus and anti-DNA autoantibody production. 11(12), 850-855.

Konstantinos Katsanos, Paraskevi Voulgari, Epameinondas Tsianos (2012) Inflammatory bowel disease and lupus: A systematic review of the literature. 6(7), 735-742.

Martin Aringer, Winfried Graninger, Günter Steiner, Josef Smolen (2004) Safety and efficacy of tumor necrosis factor α blockade in systemic lupus erythematosus: An open‐label study. 50(10), 3161-3169.

L-J Zhu, X Yang, X-Q Yu (2010) Anti-TNF-α Therapies in Systemic Lupus Erythematosus.

E Eliadou, A Day, M Thompson-Fawcett, R Gearry, D Rowbotham, R Walmsley (1423) New Zealand Society of Gastroenterology Guidelines for the Management of Refractory Ulcerative Colitis. 16, 63-76.

V Fazio, R Kiran, F Remzi, J Coffey, H Heneghan, H Kirat (2013) Ileal pouch anal anastomosis: analysis of outcome and quality of life in 3707 patients. 257(4), 679-685.

Nacir Oussama, Aboutarik Fatimaezzahra, Aiterrami Adil, Samlani Zouhour, Krati Khadija, Oubaha Sofia (2020) Ulcerative Colitis and Systemic Lupus Erythematosus: An Unusual Association with Diagnostic and Therapeutic Difficulties. 08(01), 51-56.